Загрузка...
647. Adoption of the updated fluoroquinolones breakpoints for Gram negative bacteria in clinical microbiology laboratories
BACKGROUND: Despite the multiple safety warnings related to fluoroquinolones (FQs) treatment, their use remains unavoidable in several occasions due to their broad spectrum of coverage including activity against multi-drug resistant glucose non-fermenting Gram-negative bacteria such as Pseudomonas s...
Сохранить в:
| Опубликовано в: : | Open Forum Infect Dis |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7776592/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.841 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|